Organon & Co (NYSE:OGN) has a beta value of 0.57 and has seen 7.47 million shares traded in the last trading session. The company, currently valued at $2.19B, closed the last trade at $8.44 per share which meant it lost -$0.27 on the day or -3.10% during that session. The OGN stock price is -173.7% off its 52-week high price of $23.10 and 4.62% above the 52-week low of $8.05.
The consensus among analysts is that Organon & Co (OGN) is Buy stock at the moment, with a recommendation rating of 3.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 1 out of 3 have rated it as a Hold, with 2 advising it as a Buy. 0 have rated the stock as Underweight.
Organon & Co (NYSE:OGN) trade information
Sporting -3.10% in the red in last session, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the OGN stock price touched $8.44 or saw a rise of 8.46%. Year-to-date, Organon & Co shares have moved -43.43%, while the 5-day performance has seen it change -7.56%. Over the past 30 days, the shares of Organon & Co (NYSE:OGN) have changed -24.51%.
Wall Street analysts have a consensus price target for the stock at $10, which means that the shares’ value could jump 15.6% from current levels. The projected low price target is $10.0 while the price target rests at a high of $10.0. In that case, then, we find that the current price level is -18.48% off the targeted high while a plunge would see the stock gain -18.48% from current levels.
Organon & Co (OGN) estimates and forecasts
The company’s shares have lost -47.64% over the past 6 months.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -23.49% over the past 5 years. Earnings growth for 2025 is a modest -5.57% while over the next 5 years, the company’s earnings are expected to decrease by -0.14%.
OGN Dividends
Organon & Co is expected to release its next earnings report in June this year, and investors are excited at the prospect of better dividends despite the company’s debt issue. The forward dividend is 0.86 at a share yield of 10.19%. The company’s dividend yield has gone up over the past 12 months.
Organon & Co (NYSE:OGN)’s Major holders
The top two institutional holders are BLACKROCK INC. with over 32.58 million shares worth more than $674.39 million. As of 2024-06-30, BLACKROCK INC. held 12.6625% of shares outstanding.
The other major institutional holder is VANGUARD GROUP INC, with the holding of over 30.21 million shares as of 2024-06-30. The firm’s total holdings are worth over $625.41 million and represent 11.7429% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are iShares Trust-iShares Core S&P Small-Cap ETF and Pacer Funds Trust-Pacer US Cash Cows 100 ETF . As of Mar 31, 2025 , the former fund manager holds about 6.13% shares in the company for having 15.93 shares of worth $134.41 million while later fund manager owns 11.13 shares of worth $93.94 million as of Jan 31, 2025 , which makes it owner of about 4.28% of company’s outstanding stock.
